Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: a comparison of serum Krebs von Lungen-6 and thymus and activation-regulated chemokine/CC chemokine ligand 17

Hiromichi YamaneDepartment of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan, [email protected]Correspondence[email protected]

Nobuaki OchiDepartment of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan, [email protected]

Yasunari NagasakiDepartment of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan, [email protected]

Tomoko YamagishiDepartment of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan, [email protected]

Yoshihiro HondaDepartment of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan, [email protected]

Nozomu NakagawaDepartment of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan, [email protected]

Masami TakeyamaDepartment of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan, [email protected]

Hidekazu NakanishiDepartment of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan, [email protected]

Nagio TakigawaDepartment of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan, [email protected]

Your download is now in progress and you may close this window